DNA Brands Statistics
Total Valuation
DNA Brands has a market cap or net worth of 323,479.
Market Cap | 323,479 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
DNA Brands has 3.23 billion shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 3.23B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.00 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 14.54% |
Revenue Per Employee | 124,507 |
Profits Per Employee | -622,736 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.76% in the last 52 weeks. The beta is 1.43, so DNA Brands's price volatility has been higher than the market average.
Beta (5Y) | 1.43 |
52-Week Price Change | -82.76% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 45.42 |
Average Volume (20 Days) | 1,158,755 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, DNA Brands had revenue of 249,013 and -1.25 million in losses. Loss per share was -0.28.
Revenue | 249,013 |
Gross Profit | 249,013 |
Operating Income | -243,528 |
Pretax Income | -1.25M |
Net Income | -1.25M |
EBITDA | -239,664 |
EBIT | -243,528 |
Loss Per Share | -0.28 |
Balance Sheet
The company has 14,577 in cash and 2.14 million in debt, giving a net cash position of -2.12 million or -0.00 per share.
Cash & Cash Equivalents | 14,577 |
Total Debt | 2.14M |
Net Cash | -2.12M |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -1.67M |
Book Value Per Share | -0.92 |
Working Capital | -2.69M |
Cash Flow
Operating Cash Flow | -1.10M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -97.80% |
Pretax Margin | -500.16% |
Profit Margin | n/a |
EBITDA Margin | -96.25% |
EBIT Margin | -97.80% |
FCF Margin | n/a |
Dividends & Yields
DNA Brands does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11,406.64% |
Shareholder Yield | -11,406.64% |
Earnings Yield | -385.02% |
FCF Yield | n/a |
Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.005.
Last Split Date | Dec 9, 2020 |
Split Type | Reverse |
Split Ratio | 0.005 |
Scores
DNA Brands has an Altman Z-Score of -46.91. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -46.91 |
Piotroski F-Score | n/a |